SpyGlass Pharma, Inc. (SGP) stock
SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$29.68−1.75 (-5.58%)
Close on Nov 18, 2026Market cap $992.74MP/E –Yield –
SpyGlass Pharma operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -$32.70M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$32.70M | – |
| FY2024 | Dec 31, 2024 | -$22.03M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$14.84M | – |
| Q1 FY2026 | Mar 31, 2026 | -$13.54M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.33M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.20M | – |
See a number that looks wrong?